Page 562 - Enfeksiyon Hastalıkları Kitabı

542 Enfeksiyon Hastalıkları

Yilmaz M, Bilir YA, Aygün G, Erzin Y, Ozturk R, Celik AF. Pros- Zalmanovici TA, Green H, Paul M, Yaphe J, Leibovici L. An-
pective observational study on antibiotic-associated bloody timicrobial agents for treating uncomplicated urinary tract
diarrhea: report of 21 cases with a long-term follow-up from infection in women (Review). Cochrane Database of Syste-
Turkey. Eur J Gastroenterol Hepatol. 2012 ;24:688-694. matic Reviews 2010, Issue 10. Art. No: CD007182.
Yousaf MZ, Qasim M, Zia S, Khan Mu, Ashfaq UA, Khan Zeitler K, Salvas B, Stevens V, Brown J. Aztreonam lysine for in-
S.Rabies molecular virology, diagnosis, prevention and tre- halation: new formulation of an old antibiotic. Am J Health
atment. Virol J. 2012; 21:9:50. Syst Pharm 2012;69(2):107-115.
Yu Cy, Ang GY, Chua AL et al. Dry-reagent gold nano-particle Zhang JC, Sun L, Nie QH. Botulism, where are we now? Clinical
based lateral flow biosensor fort he simultaneous detection Toxicology. 2010; 48, 867-879.

of Vibrio cholerae serogroups O1 and O139. J Microbiol Zimmerli W. Infection and musculoskeletal conditions: Prosthe-
Methods 2011;86:277-282.
tic-joint-associated infections. Best Pract Res Clin Rheuma-
Yu L, Zhou Y, Wang R et al. Multipl antibiotic resistance of Vib- tol 2006;20:1045-1063.
rio cholerae serogroup O139 in China from 1993 to 2009. Zuckerman JM, Qamar F, Bono BR. Macrolides, ketolides, and
PloS One 2012;7:e38633. glycylcyclines: azithromycin, clarithromycin, telithromycin,
Zahar JR, Timsit JF, Garrouste-Orgeas M, et al. Outcomes in se- tigecycline. Infect Dis Clin North Am. 2009;23(4):997-1026.
vere sepsis and patients with septic shock: pathogen species
and infection sites are not associated with mortality. Crit
Care Med 2011; 39:1886.